• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

肯尼亚市场上抗酸剂品牌的中和能力及钠含量。

The neutralizing capacity and sodium content of antacid brands on the Kenyan market.

作者信息

Kibwage I O, Machine A, Hagos B, Hoogmartens J

机构信息

Department of Pharmacy, College of Health Sciences, University of Nairobi.

出版信息

East Afr Med J. 1995 Mar;72(3):194-7.

PMID:7796775
Abstract

Seventeen brands of antacid products available on the Kenya market were investigated for their acid neutralising capacity and sodium content. Thirteen tablet products gave neutralising capacity per tablet of between 4.7 to 14.12 mMol hydrochloric acid. The neutralising capacities for the suspensions ranged between 11.97 to 34.32 mMol hydrochloric acid for 10ml suspension. The lowest neutralising capacities were obtained for products based on compound magnesium trisilicate and higher capacities for those containing magaldrate, or magnesium hydroxide or magnesium carbonate in combination with other ingredients. The fastest rate of neutralization was obtained with preparations containing carbonates and the lowest by compound magnesium trisilicate. The sodium content for the preparations was between < 0.001 mEq to 0.732 mEq sodium per minimum recommended dose. The study shows a high degree of variation in both the acid neutralising capacities and the sodium content of the different brands investigated.

摘要

对肯尼亚市场上现有的17种抗酸产品品牌进行了酸中和能力和钠含量调查。13种片剂产品每片的中和能力为4.7至14.12毫摩尔盐酸。10毫升悬浮液的中和能力在11.97至34.32毫摩尔盐酸之间。基于复方三硅酸镁的产品中和能力最低,而含有铝镁加、氢氧化镁或碳酸镁与其他成分组合的产品中和能力较高。含碳酸盐的制剂中和速度最快,复方三硅酸镁的中和速度最慢。制剂的钠含量按最低推荐剂量计算,每剂含钠量在<0.001毫当量至0.732毫当量之间。该研究表明,所调查的不同品牌产品在酸中和能力和钠含量方面都存在很大差异。

相似文献

1
The neutralizing capacity and sodium content of antacid brands on the Kenyan market.肯尼亚市场上抗酸剂品牌的中和能力及钠含量。
East Afr Med J. 1995 Mar;72(3):194-7.
2
A comparative study of the neutralising capacity of eight brands of antacids.
East Afr Med J. 1989 Jun;66(6):408-10.
3
Evaluation of commercially available antacid tablets.
Trop Gastroenterol. 1993 Oct-Dec;14(4):139-43.
4
In vitro comparison of the antacid potencies of almagate in tablets and suspension with those of other commercially available antacid preparations.将铝镁加片剂和混悬液与其他市售抗酸制剂的抗酸效力进行体外比较。
Arzneimittelforschung. 1984;34(10A):1360-4.
5
In vitro evaluation of liquid antacid products.
Am J Hosp Pharm. 1982 Feb;39(2):300-2.
6
Evaluation of antacid suspensions containing aluminum hydroxide and magnesium hydroxide.含氢氧化铝和氢氧化镁的抗酸混悬液的评估。
Am J Hosp Pharm. 1982 Nov;39(11):1925-30.
7
In vitro buffering capacities of proprietary non-particulate antacids available in New Zealand.
Anaesth Intensive Care. 1994 Apr;22(2):184-6. doi: 10.1177/0310057X9402200212.
8
Invitro evaluation of the neutralising capacity of twenty brands of antacids in Lagos, Nigeria.尼日利亚拉各斯二十个品牌抗酸剂中和能力的体外评估。
Nig Q J Hosp Med. 2008 Jul-Sep;18(3):153-5. doi: 10.4314/nqjhm.v18i3.45017.
9
Acid-neutralizing capacity and sodium content of antacid products from Belgium.
Clin Ther. 1984;6(2):151-4.
10
Evaluation of buffering capacity and acid neutralizing-pH time profile of antacids.抗酸剂的缓冲能力及酸中和 - pH时间曲线评估。
J Formos Med Assoc. 1998 Oct;97(10):704-10.